R&D LNPs: The unknown enabler behind mRNA vaccines Drug delivery technologies are crucial to allow drugs to reach their full potential, and yet they rarely receive much spotlight.
Events Partner Content Next Generation Lipid-Based Nanoparticles Delivery Summit | ... Harness Safe & Efficacious Lipid-Based Delivery for Novel Therapeutics Beyond RNA & Hepatic Tissue
News UK's Claret Capital raises €575m for European biotechs London-based Claret Capital Partners has closed its fourth European Growth Capital Fund, raising €575m for "Europe's boldest innovators."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
